About Entest BioMedical

Entest BioMedical, Inc. engages in the development and commercialization of immunotherapeutic therapies for the veterinary market. The company is developing ImenVax family of canine cancer vaccines, which include ImenVax I, a therapeutic for canine cancer, which is involved in isolating tumor cells from the patient and placing the cells into a cell implant device that is inserted subcutaneously into the patient; ImenVax II that utilizes cell lines for sustained release of immunologically relevanView more